Susanne Steggerda

2.9k total citations
23 papers, 695 citations indexed

About

Susanne Steggerda is a scholar working on Molecular Biology, Biotechnology and Immunology. According to data from OpenAlex, Susanne Steggerda has authored 23 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Biotechnology and 6 papers in Immunology. Recurrent topics in Susanne Steggerda's work include Cancer Research and Treatments (7 papers), RNA Research and Splicing (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Susanne Steggerda is often cited by papers focused on Cancer Research and Treatments (7 papers), RNA Research and Splicing (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Susanne Steggerda collaborates with scholars based in United States, Netherlands and Germany. Susanne Steggerda's co-authors include Bryce M. Paschal, W. Scott Moye‐Rowley, Eric A. Epping, Sean T. Coleman, John A. Wemmie, Joseph J. Buggy, Michelle Francesco, Betty Chang, David Auble and Ben E. Black and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Susanne Steggerda

23 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanne Steggerda United States 11 469 173 153 102 93 23 695
Kasyapa S. Chitta United States 12 275 0.6× 158 0.9× 119 0.8× 88 0.9× 119 1.3× 29 483
Kyoichiro Higashi Japan 11 399 0.9× 112 0.6× 65 0.4× 115 1.1× 110 1.2× 15 628
Adriana E. Tron United States 16 706 1.5× 48 0.3× 60 0.4× 111 1.1× 199 2.1× 28 864
Daniela Bressanin Italy 15 515 1.1× 62 0.4× 33 0.2× 68 0.7× 132 1.4× 26 784
Jeannie Kibitel United States 15 480 1.0× 176 1.0× 52 0.3× 163 1.6× 99 1.1× 21 905
Ze-Yan Zhang China 13 444 0.9× 33 0.2× 67 0.4× 60 0.6× 158 1.7× 33 618
Kian Cheng Tan-Un Hong Kong 9 619 1.3× 107 0.6× 27 0.2× 32 0.3× 80 0.9× 15 833
Ružica Bago Croatia 11 513 1.1× 30 0.2× 87 0.6× 70 0.7× 108 1.2× 18 750
Éric Cabannes France 10 269 0.6× 36 0.2× 106 0.7× 123 1.2× 137 1.5× 12 502

Countries citing papers authored by Susanne Steggerda

Since Specialization
Citations

This map shows the geographic impact of Susanne Steggerda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Steggerda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Steggerda more than expected).

Fields of papers citing papers by Susanne Steggerda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Steggerda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Steggerda. The network helps show where Susanne Steggerda may publish in the future.

Co-authorship network of co-authors of Susanne Steggerda

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Steggerda. A scholar is included among the top collaborators of Susanne Steggerda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Steggerda. Susanne Steggerda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jason, Sacha J. Holland, Francesco Parlati, et al.. (2022). Abstract 1816: Identification of novel VPS4A inhibitors for the treatment of VPS4B-deleted cancers. Cancer Research. 82(12_Supplement). 1816–1816. 1 indexed citations
2.
Emberley, Ethan, Alison Pan, Jason Chen, et al.. (2021). The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma. PLoS ONE. 16(11). e0259241–e0259241. 33 indexed citations
3.
MacKinnon, Andrew L., Jason Chen, Tony Chieh‐Ting Huang, et al.. (2020). 705 Anti-tumor activity of CB-668, a potent, selective and orally bioavailable small-molecule inhibitor of the immuno-suppressive enzyme Interleukin 4 (IL-4)-Induced Gene 1 (IL4I1). SHILAP Revista de lepidopterología. A423.2–A424. 6 indexed citations
4.
Emberley, Ethan, Mark K. Bennett, Matthew Gross, et al.. (2018). Abstract 3509: The glutaminase inhibitor CB-839 synergizes with CDK4/6 and PARP inhibitors in pre-clinical tumor models. Cancer Research. 78(13_Supplement). 3509–3509. 12 indexed citations
5.
Works, Melissa, Mark K. Bennett, Ethan Emberley, et al.. (2016). Abstract 552: Immuno-oncology agent CB-1158 is a potent and selective arginase inhibitor and causes an immune-mediated anti-tumor response. Cancer Research. 76(14_Supplement). 552–552. 10 indexed citations
6.
Emberley, Ethan, Mark K. Bennett, Matt Gross, et al.. (2016). CB-839, a selective glutaminase inhibitor, has anti-tumor activity in renal cell carcinoma and synergizes with everolimus and receptor tyrosine kinase inhibitors. European Journal of Cancer. 69. S124–S124. 6 indexed citations
7.
Steggerda, Susanne, Mark K. Bennett, Jason Chen, et al.. (2016). Abstract B045: Arginase inhibitor CB-1158 elicits immune-mediated antitumor responses as a single agent and in combination with other immunotherapies. Cancer Immunology Research. 4(11_Supplement). B045–B045. 2 indexed citations
8.
Gross, Matthew, Jason Chen, Ethan Emberley, et al.. (2015). Abstract A195: CB-1158 inhibits the immuno-oncology target arginase and causes an immune mediated anti-tumor response. Molecular Cancer Therapeutics. 14(12_Supplement_2). A195–A195. 4 indexed citations
9.
Rodriguez, Mirna L.M., Winter Zhang, Mark K. Bennett, et al.. (2015). Abstract 4711: CB-839, a selective glutaminase inhibitor, synergizes with signal transduction pathway inhibitors to enhance anti-tumor activity. Cancer Research. 75(15_Supplement). 4711–4711. 4 indexed citations
10.
Chang, Betty, Michelle Francesco, Martin F. M. de Rooij, et al.. (2013). Egress of CD19+CD5+ cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients. Blood. 122(14). 2412–2424. 159 indexed citations
11.
Chang, Betty, Richard R. Furman, Marc Zapatka, et al.. (2013). Use of tumor genomic profiling to reveal mechanisms of resistance to the BTK inhibitor ibrutinib in chronic lymphocytic leukemia (CLL).. Journal of Clinical Oncology. 31(15_suppl). 7014–7014. 30 indexed citations
12.
Gao, Shan, Claudia P. Miller, Joy M. Fulbright, et al.. (2010). PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells. International Journal of Cell Biology. 2010. 1–10. 28 indexed citations
13.
14.
Steggerda, Susanne & Bryce M. Paschal. (2002). Regulation of nuclear import and export by the GTPase ran. International review of cytology. 217. 41–91. 54 indexed citations
15.
Steggerda, Susanne & Bryce M. Paschal. (2001). Identification of a Conserved Loop in Mog1 that Releases GTP from Ran. Traffic. 2(11). 804–811. 10 indexed citations
16.
Steggerda, Susanne & Bryce M. Paschal. (2000). The Mammalian Mog1 Protein Is a Guanine Nucleotide Release Factor for Ran. Journal of Biological Chemistry. 275(30). 23175–23180. 45 indexed citations
17.
Steggerda, Susanne, Ben E. Black, & Bryce M. Paschal. (2000). Monoclonal Antibodies to NTF2 Inhibit Nuclear Protein Import by Preventing Nuclear Translocation of the GTPase Ran. Molecular Biology of the Cell. 11(2). 703–719. 36 indexed citations
18.
Coleman, Sean T., Eric A. Epping, Susanne Steggerda, & W. Scott Moye‐Rowley. (1999). Yap1p Activates Gene Transcription in an Oxidant-Specific Fashion. Molecular and Cellular Biology. 19(12). 8302–8313. 127 indexed citations
19.
Auble, David & Susanne Steggerda. (1999). Testing for DNA Tracking by MOT1, a SNF2/SWI2 Protein Family Member. Molecular and Cellular Biology. 19(1). 412–423. 25 indexed citations
20.
Wemmie, John A., Susanne Steggerda, & W. Scott Moye‐Rowley. (1997). The Saccharomyces cerevisiae AP-1 Protein Discriminates between Oxidative Stress Elicited by the Oxidants H2O2 and Diamide. Journal of Biological Chemistry. 272(12). 7908–7914. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kasyapa S. Chitta Breakdown of academic impact, for papers by Kyoichiro Higashi Breakdown of academic impact, for papers by Adriana E. Tron Breakdown of academic impact, for papers by Daniela Bressanin Breakdown of academic impact, for papers by Jeannie Kibitel Breakdown of academic impact, for papers by Ze-Yan Zhang Breakdown of academic impact, for papers by Kian Cheng Tan-Un Breakdown of academic impact, for papers by Ružica Bago Breakdown of academic impact, for papers by Éric Cabannes
Rankless by CCL
2026